SS Innovations International (SSII) drew fresh attention after issuing preliminary unaudited revenue guidance, signaling a sharp step up in its surgical robotics business for the fourth quarter and full year 2025.

Even with the new revenue guidance pointing to stronger business momentum, SS Innovations International’s share price has been under pressure, with a 30 day share price return of 10.9% and a 90 day share price return of 40.27%, contributing to a 1 year total shareholder return of 26.14%.

If this earnings update has you rethinking your watchlist, it could be a good moment to compare SS Innovations International with other healthcare stocks that are also trying to reshape medical technology.

With shares down over the past year despite guidance for higher revenues, the real question is whether SS Innovations International is quietly trading at a discount or whether the market is already pricing in much of that future growth.

Preferred Price-to-Sales of 28.7x: Is It Justified?

On the latest data, SS Innovations International trades on a P/S of 28.7x, which sits against a last close of $5.36 and suggests the market is paying a high premium for each dollar of current revenue.

The P/S ratio compares the company’s market value to its revenue, so a higher multiple usually reflects strong expectations around future sales or business potential. For a commercial stage surgical robotics company that is still loss making, a rich P/S can indicate that investors are focusing more on future scale than on current profitability.

Here, that premium stands out. The US Medical Equipment industry average P/S is 3.3x, so SS Innovations International’s 28.7x multiple is more than 8x higher. It is also above the 7x peer average flagged in the data. With no fair ratio available to benchmark what level the market could gravitate toward, the current valuation rests largely on how investors view the company’s long term revenue opportunity and path to profitability.

Result: Price-to-Sales of 28.7x (OVERVALUED)

However, you still have to weigh clear risks, including ongoing losses, with net income at a loss of $11.58m, as well as sharp recent share price declines.

Build Your Own SS Innovations International Narrative

If you see the numbers differently or want to stress test your own assumptions, you can build a personalized SS Innovations International thesis in just a few minutes, starting with Do it your way.

A great starting point for your SS Innovations International research is our analysis highlighting 2 important warning signs that could impact your investment decision.

Looking for more investment ideas?

If you only focus on one company, you could miss out on other clear opportunities, so widen your search now and give your portfolio more options to work with.

• Target potential mispricings by checking out these 864 undervalued stocks based on cash flows that may offer more attractive entry points based on their cash flows.
• Ride the next wave of tech by scanning these 24 AI penny stocks that are tied to artificial intelligence themes across different parts of the market.
• Tap into digital asset trends by reviewing these 18 cryptocurrency and blockchain stocks positioned around cryptocurrency and blockchain related business models.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.